APO RESEARCH · REPORT
Organic Infant Formula
Organic infant formula is uses the finest organic ingredients in milk, which means no chemical pesticides and no GM ingredients.
Product & engineering
Understand the product.
Organic infant formula is uses the finest organic ingredients in milk, which means no chemical pesticides and no GM ingredients.
Organic farming is a method of production that is concerned with respecting natural balances. It is committed to sustainable management, respecting natural balances and biodiversity, and producing high quality products in a way that is not harmful to the environment or health.
Selected research
Market Structure
Global Organic Infant Formula Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Organic infant formula is uses the finest organic ingredients in milk, which means no chemical pesticides and no GM ingredients.
Organic farming is a method of production that is concerned with respecting natural balances. It is committed to sustainable management, respecting natural balances and biodiversity, and producing high quality products in a way that is not harmful to the environment or health.
At present, the major manufacturers of organic infant formula are Abbott, HiPP, Holle, Bellamy, Topfer, etc. Abbott is the world leader, holding 21% consumption market share. Europe is the largest market, with a share about 52%, followed by Asia Pacific and North America with the share both about 22%.
Read the full market overview
This report provides an overview of the global Organic Infant Formula market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Organic Infant Formula and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Organic Infant Formula sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Organic Infant Formula market size, projected growth trends, production technologies, key applications, and end-use industries.
Organic Infant Formula Segment by Company
Abbott
HiPP
Holle
Bellamy
Topfer
Supermum
The Hain Celestial Group
Nature One
Perrigo
Babybio
Gittis
Humana
Bimbosan
Ausnutria
Nutribio
HealthyTimes
Arla
Angisland
Yeeper
Wyeth
Kendamil
Nestle
Feihe
JUNLEBAO
YILI
BIOSTIME
Biobim
Organic Infant Formula Segment by Type
Wet Process Type
Dry Process Type
Others
Organic Infant Formula Segment by Application
First Stage
Second Stage
Third Stage
Organic Infant Formula Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organic Infant Formula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Organic Infant Formula and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organic Infant Formula.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Organic Infant Formula market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Organic Infant Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Organic Infant Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Organic Infant Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Wet Process Type
- Dry Process Type
- Others
Applications
- First Stage
- Second Stage
- Third Stage
Companies covered
- Abbott
- HiPP
- Holle
- Bellamy
- Topfer
- Supermum
- The Hain Celestial Group
- Nature One
- Perrigo
- Babybio
- Gittis
- Humana
- Bimbosan
- Ausnutria
- Nutribio
- HealthyTimes
- Arla
- Angisland
- Yeeper
- Wyeth
- Kendamil
- Nestle
- Feihe
- JUNLEBAO
- YILI
- BIOSTIME
- Biobim
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Organic Infant Formula Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Organic Infant Formula Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Organic Infant Formula Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Organic Infant Formula Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Organic Infant Formula Market Dynamics
- 2.1 Organic Infant Formula Industry Trends
- 2.2 Organic Infant Formula Industry Drivers
- 2.3 Organic Infant Formula Industry Opportunities and Challenges
- 2.4 Organic Infant Formula Industry Restraints
3 Organic Infant Formula Market by Manufacturers
- 3.1 Global Organic Infant Formula Revenue by Manufacturers (2021-2026)
- 3.2 Global Organic Infant Formula Sales by Manufacturers (2021-2026)
- 3.3 Global Organic Infant Formula Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Organic Infant Formula Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Organic Infant Formula Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Organic Infant Formula Manufacturers, Product Type & Application
- 3.7 Global Organic Infant Formula Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Organic Infant Formula Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Organic Infant Formula Players Market Share by Revenue in 2025
- 3.8.3 2025 Organic Infant Formula Tier 1, Tier 2, and Tier 3
4 Organic Infant Formula Market by Type
- 4.1 Organic Infant Formula Type Introduction
- 4.1.1 Wet Process Type
- 4.1.2 Dry Process Type
- 4.1.3 Others
- 4.2 Global Organic Infant Formula Sales by Type
- 4.2.1 Global Organic Infant Formula Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Organic Infant Formula Sales by Type (2021-2032)
- 4.2.3 Global Organic Infant Formula Sales Market Share by Type (2021-2032)
- 4.3 Global Organic Infant Formula Revenue by Type
- 4.3.1 Global Organic Infant Formula Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Organic Infant Formula Revenue by Type (2021-2032)
- 4.3.3 Global Organic Infant Formula Revenue Market Share by Type (2021-2032)
5 Organic Infant Formula Market by Application
- 5.1 Organic Infant Formula Application Introduction
- 5.1.1 First Stage
- 5.1.2 Second Stage
- 5.1.3 Third Stage
- 5.2 Global Organic Infant Formula Sales by Application
- 5.2.1 Global Organic Infant Formula Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Organic Infant Formula Sales by Application (2021-2032)
- 5.2.3 Global Organic Infant Formula Sales Market Share by Application (2021-2032)
- 5.3 Global Organic Infant Formula Revenue by Application
- 5.3.1 Global Organic Infant Formula Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Organic Infant Formula Revenue by Application (2021-2032)
- 5.3.3 Global Organic Infant Formula Revenue Market Share by Application (2021-2032)
6 Global Organic Infant Formula Sales by Region
- 6.1 Global Organic Infant Formula Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Organic Infant Formula Sales by Region (2021-2032)
- 6.2.1 Global Organic Infant Formula Sales by Region (2021-2026)
- 6.2.2 Global Organic Infant Formula Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Organic Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Organic Infant Formula Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Organic Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Organic Infant Formula Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Organic Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Organic Infant Formula Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Organic Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Organic Infant Formula Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Organic Infant Formula Revenue by Region
- 7.1 Global Organic Infant Formula Revenue by Region
- 7.1.1 Global Organic Infant Formula Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Organic Infant Formula Revenue by Region (2021-2026)
- 7.1.3 Global Organic Infant Formula Revenue by Region (2027-2032)
- 7.1.4 Global Organic Infant Formula Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Organic Infant Formula Revenue (2021-2032)
- 7.2.2 North America Organic Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Organic Infant Formula Revenue (2021-2032)
- 7.3.2 Europe Organic Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Organic Infant Formula Revenue (2021-2032)
- 7.4.2 Asia-Pacific Organic Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Organic Infant Formula Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Organic Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Abbott
- 8.1.1 Abbott Company Information
- 8.1.2 Abbott Business Overview
- 8.1.3 Abbott Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Abbott Organic Infant Formula Product Portfolio
- 8.1.5 Abbott Recent Developments
- 8.2 HiPP
- 8.2.1 HiPP Company Information
- 8.2.2 HiPP Business Overview
- 8.2.3 HiPP Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 HiPP Organic Infant Formula Product Portfolio
- 8.2.5 HiPP Recent Developments
- 8.3 Holle
- 8.3.1 Holle Company Information
- 8.3.2 Holle Business Overview
- 8.3.3 Holle Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Holle Organic Infant Formula Product Portfolio
- 8.3.5 Holle Recent Developments
- 8.4 Bellamy
- 8.4.1 Bellamy Company Information
- 8.4.2 Bellamy Business Overview
- 8.4.3 Bellamy Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Bellamy Organic Infant Formula Product Portfolio
- 8.4.5 Bellamy Recent Developments
- 8.5 Topfer
- 8.5.1 Topfer Company Information
- 8.5.2 Topfer Business Overview
- 8.5.3 Topfer Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Topfer Organic Infant Formula Product Portfolio
- 8.5.5 Topfer Recent Developments
- 8.6 Supermum
- 8.6.1 Supermum Company Information
- 8.6.2 Supermum Business Overview
- 8.6.3 Supermum Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Supermum Organic Infant Formula Product Portfolio
- 8.6.5 Supermum Recent Developments
- 8.7 The Hain Celestial Group
- 8.7.1 The Hain Celestial Group Company Information
- 8.7.2 The Hain Celestial Group Business Overview
- 8.7.3 The Hain Celestial Group Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 The Hain Celestial Group Organic Infant Formula Product Portfolio
- 8.7.5 The Hain Celestial Group Recent Developments
- 8.8 Nature One
- 8.8.1 Nature One Company Information
- 8.8.2 Nature One Business Overview
- 8.8.3 Nature One Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Nature One Organic Infant Formula Product Portfolio
- 8.8.5 Nature One Recent Developments
- 8.9 Perrigo
- 8.9.1 Perrigo Company Information
- 8.9.2 Perrigo Business Overview
- 8.9.3 Perrigo Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Perrigo Organic Infant Formula Product Portfolio
- 8.9.5 Perrigo Recent Developments
- 8.10 Babybio
- 8.10.1 Babybio Company Information
- 8.10.2 Babybio Business Overview
- 8.10.3 Babybio Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Babybio Organic Infant Formula Product Portfolio
- 8.10.5 Babybio Recent Developments
- 8.11 Gittis
- 8.11.1 Gittis Company Information
- 8.11.2 Gittis Business Overview
- 8.11.3 Gittis Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Gittis Organic Infant Formula Product Portfolio
- 8.11.5 Gittis Recent Developments
- 8.12 Humana
- 8.12.1 Humana Company Information
- 8.12.2 Humana Business Overview
- 8.12.3 Humana Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Humana Organic Infant Formula Product Portfolio
- 8.12.5 Humana Recent Developments
- 8.13 Bimbosan
- 8.13.1 Bimbosan Company Information
- 8.13.2 Bimbosan Business Overview
- 8.13.3 Bimbosan Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Bimbosan Organic Infant Formula Product Portfolio
- 8.13.5 Bimbosan Recent Developments
- 8.14 Ausnutria
- 8.14.1 Ausnutria Company Information
- 8.14.2 Ausnutria Business Overview
- 8.14.3 Ausnutria Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Ausnutria Organic Infant Formula Product Portfolio
- 8.14.5 Ausnutria Recent Developments
- 8.15 Nutribio
- 8.15.1 Nutribio Company Information
- 8.15.2 Nutribio Business Overview
- 8.15.3 Nutribio Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Nutribio Organic Infant Formula Product Portfolio
- 8.15.5 Nutribio Recent Developments
- 8.16 HealthyTimes
- 8.16.1 HealthyTimes Company Information
- 8.16.2 HealthyTimes Business Overview
- 8.16.3 HealthyTimes Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 HealthyTimes Organic Infant Formula Product Portfolio
- 8.16.5 HealthyTimes Recent Developments
- 8.17 Arla
- 8.17.1 Arla Company Information
- 8.17.2 Arla Business Overview
- 8.17.3 Arla Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Arla Organic Infant Formula Product Portfolio
- 8.17.5 Arla Recent Developments
- 8.18 Angisland
- 8.18.1 Angisland Company Information
- 8.18.2 Angisland Business Overview
- 8.18.3 Angisland Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 Angisland Organic Infant Formula Product Portfolio
- 8.18.5 Angisland Recent Developments
- 8.19 Yeeper
- 8.19.1 Yeeper Company Information
- 8.19.2 Yeeper Business Overview
- 8.19.3 Yeeper Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.19.4 Yeeper Organic Infant Formula Product Portfolio
- 8.19.5 Yeeper Recent Developments
- 8.20 Wyeth
- 8.20.1 Wyeth Company Information
- 8.20.2 Wyeth Business Overview
- 8.20.3 Wyeth Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.20.4 Wyeth Organic Infant Formula Product Portfolio
- 8.20.5 Wyeth Recent Developments
- 8.21 Kendamil
- 8.21.1 Kendamil Company Information
- 8.21.2 Kendamil Business Overview
- 8.21.3 Kendamil Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.21.4 Kendamil Organic Infant Formula Product Portfolio
- 8.21.5 Kendamil Recent Developments
- 8.22 Nestle
- 8.22.1 Nestle Company Information
- 8.22.2 Nestle Business Overview
- 8.22.3 Nestle Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.22.4 Nestle Organic Infant Formula Product Portfolio
- 8.22.5 Nestle Recent Developments
- 8.23 Feihe
- 8.23.1 Feihe Company Information
- 8.23.2 Feihe Business Overview
- 8.23.3 Feihe Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.23.4 Feihe Organic Infant Formula Product Portfolio
- 8.23.5 Feihe Recent Developments
- 8.24 JUNLEBAO
- 8.24.1 JUNLEBAO Company Information
- 8.24.2 JUNLEBAO Business Overview
- 8.24.3 JUNLEBAO Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.24.4 JUNLEBAO Organic Infant Formula Product Portfolio
- 8.24.5 JUNLEBAO Recent Developments
- 8.25 YILI
- 8.25.1 YILI Company Information
- 8.25.2 YILI Business Overview
- 8.25.3 YILI Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.25.4 YILI Organic Infant Formula Product Portfolio
- 8.25.5 YILI Recent Developments
- 8.26 BIOSTIME
- 8.26.1 BIOSTIME Company Information
- 8.26.2 BIOSTIME Business Overview
- 8.26.3 BIOSTIME Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.26.4 BIOSTIME Organic Infant Formula Product Portfolio
- 8.26.5 BIOSTIME Recent Developments
- 8.27 Biobim
- 8.27.1 Biobim Company Information
- 8.27.2 Biobim Business Overview
- 8.27.3 Biobim Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.27.4 Biobim Organic Infant Formula Product Portfolio
- 8.27.5 Biobim Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Organic Infant Formula Value Chain Analysis
- 9.1.1 Organic Infant Formula Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Organic Infant Formula Production Mode & Process
- 9.2 Organic Infant Formula Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Organic Infant Formula Distributors
- 9.2.3 Organic Infant Formula Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst